Exscientia Plc
(NASDAQ : EXAI)

( )
EXAI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. 5.53%139.397.5%$561.73m
EFXEquifax, Inc. 2.48%202.262.0%$237.75m
CRLCharles River Laboratories International, Inc. -1.10%226.064.4%$157.78m
CPRTCopart, Inc. 1.67%67.672.2%$149.24m
BAHBooz Allen Hamilton Holding Corp. 0.45%106.882.1%$130.34m
ICLRICON plc 1.51%218.692.7%$128.54m
FLTFLEETCOR Technologies, Inc. 0.04%196.284.0%$117.04m
SYNHSyneos Health, Inc. 1.93%35.960.0%$72.95m
RCMR1 RCM, Inc. -0.33%9.020.0%$72.33m
MEDPMedpace Holdings, Inc. 2.69%215.541.1%$69.28m
FOURShift4 Payments, Inc. 7.61%49.870.0%$67.66m
WEXWEX, Inc. 1.31%171.366.0%$59.37m
LFGArchaea Energy, Inc. -0.15%25.900.0%$56.71m
CHGGChegg, Inc. -0.80%29.6015.1%$55.35m
GGenpact Ltd. 0.37%46.287.2%$48.70m

Company Profile

Exscientia Plc operates as an AI-driven pharmatech company which is engaged in designing and developing patient-based drugs. The firm has designed three drugs that are in phase 1 human clinical trials. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.